Published online May 9, 2022. doi: 10.5492/wjccm.v11.i3.198
Peer-review started: December 1, 2021
First decision: January 12, 2022
Revised: January 12, 2022
Accepted: March 26, 2022
Article in press: March 26, 2022
Published online: May 9, 2022
Processing time: 157 Days and 1.6 Hours
Clinical scoring systems are required to predict complications, severity, need for intensive care unit admission, and mortality in patients with acute pancreatitis. Over the years, many scores have been developed, tested, and compared for their efficacy and accuracy. An ideal score should be rapid, reliable, and validated in different patient populations and geographical areas and should not lose relevance over time. A combination of scores or serial monitoring of a single score may increase their efficacy.
Core Tip: A score which is rapid, reproducible, reliable, and validated across different patient populations is ideally required to predict outcomes in acute pancreatitis. As most of the scores have similar efficacy, the choice of score in a particular center may depend on ease of computation and application. Sequential organ failure assessment score has been validated in various patient populations, is easy to compute and apply, and has withstood the test of time. Hence, it may be a good option, to predict outcomes in patients with acute pancreatitis.